Yahoo
KOSDAQ - Delayed Quote KRW

CLIO Cosmetics Co.,Ltd (237880.KQ)

11,240.00 -50.00 (-0.44%)
At close: 3:30:08 PM GMT+9
Chart Range Bar
Loading chart for 237880.KQ
  • Previous Close 11,290.00
  • Open 11,330.00
  • Bid 11,240.00 x --
  • Ask 11,330.00 x --
  • Day's Range 11,200.00 - 11,450.00
  • 52 Week Range 8,800.00 - 14,800.00
  • Volume 28,563
  • Avg. Volume 104,263
  • Market Cap (intraday) 196.977B
  • Beta (5Y Monthly) 0.46
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date (est.) --
  • Forward Dividend & Yield 250.00 (2.21%)
  • Ex-Dividend Date Dec 29, 2025
  • 1y Target Est 14,350.00

CLIO Cosmetics Co.,Ltd engages in sales and distribution of cosmetics products and cosmetic tools in South Korea and internationally. It offers eye liner and brow, cushion, lipstick, lip tint, shading, cream, skincare mask, hair care products, as well as body and perfumes. The company offers its products under the CLIO, peripera, goodal, DERMATORY, TYPE NUMBER, TRUE RX, and Healing Bird brands through its CLUB CLIO shopping mall, as well as provides professional services through offline stores and online malls. CLIO Cosmetics Co.,Ltd was founded in 1993 and is based in Seoul, South Korea.

cliocosmetic.com

335

Full Time Employees

December 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .

YTD Return

237880.KQ
13.74%
KOSPI Composite Index (^KS11)
34.04%

1-Year Return

237880.KQ
19.72%
KOSPI Composite Index (^KS11)
33.80%

3-Year Return

237880.KQ
55.78%
KOSPI Composite Index (^KS11)
138.51%

5-Year Return

237880.KQ
46.00%
KOSPI Composite Index (^KS11)
89.83%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 86.81B
Earnings 13.87B
Profit Margin 15.97%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
20B
40B
60B
80B
6.0%
8.0%
10.0%
12.0%
14.0%

Analyst Insights

View More

Analyst Price Targets

11,700.00
14,350.00 Average
11,240.00 Current
17,000.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.94%

  • Return on Assets (ttm)

    5.76%

  • Return on Equity (ttm)

    11.87%

  • Revenue (ttm)

    329.59B

  • Net Income Avi to Common (ttm)

    29.45B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    163.95B

  • Total Debt/Equity (mrq)

    3.37%

  • Levered Free Cash Flow (ttm)

    22.31B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: